Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: The Heart Outcomes Prevention Evaluation (HOPE)-2 trial

The HOPE-2 Investigators writing group

Research output: Contribution to journalArticlepeer-review

46 Citations (Scopus)
Original languageEnglish
Pages (from-to)47-53
Number of pages7
JournalCanadian Journal of Cardiology
Volume22
Issue number1
DOIs
Publication statusPublished - Jan 1 2006

ASJC Scopus Subject Areas

  • Cardiology and Cardiovascular Medicine

Keywords

  • Atherosclerosis
  • Clinical trials
  • Coronary disease
  • Homocysteine
  • Myocardial infarction
  • Stroke

Fingerprint

Dive into the research topics of 'Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: The Heart Outcomes Prevention Evaluation (HOPE)-2 trial'. Together they form a unique fingerprint.

Cite this